News for DSS Stock

DSS, Inc.’s Subsidiary, Impact BioMedical Inc., Announces Strategic Merger DSS, Inc. Reports Strong Q1 2025 Financial Performance, Setting the Stage for Strategic Growth Sentinel Brokers Company, Inc., a Subsidiary of DSS, Inc., Receives FINRA Approval to Act as Underwriter and Selling Group Member for Corporate Securities Offerings DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth DSS, Inc. Issues Letter to Shareholders DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value AmericaFirst Funds Trust Announces Changes to Board of Trustees DSS, Inc. Names Jason Grady as Interim Chief Executive Officer Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years DSS Inc. Wins Patent Dispute with Nichia Corporation DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical DSS Inc. Issues Letter to Shareholders DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc. DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc. DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc. DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM DSS Announces Letter to Shareholders    Impact BioMedical Scientific Partner GRDG Sciences to be Featured in New Documentary DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing Impact BioMedical Develops Quantum Antihistamine DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs DSS Strengthens and Expands Board with Appointment of Two Independent Directors Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report® Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division CORRECTION - DSS Announces Letter to Shareholders DSS Announces Letter to Shareholders DSS to Present at Aegis Virtual Conference DSS Receives $17 Million Investment from Alset EHome International DSS Acquires 25.1% of Alset International Limited DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building Impact BioMedical Announces New Bioplastics Test Results Heng Fai Ambrose Chan Joins Value Exchange International, Inc. Board of Directors DSS Provides Update on Expansion of Premier Packaging Subsidiary DSS’s American Pacific Bancorp Approaches $20M in New Loans Issued DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds DSS to Present at the Emerging Growth Conference on December 8 DSS Enters Quantitative Investment Fund Arena DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report® DSS Provides Update on its Liquid Value Asset Management Subsidiary DSS, Inc. Issued New CUSIP Number in Conjunction with Previously Announced Name Change Document Security Systems, Inc. to Change Its Name to DSS, Inc. to Reflect Sweeping Organizational Changes and Ongoing Business Expansions DSS Invests $40 Million into American Pacific Bancorp DSS Receives $15 Million Investment from Alset EHome International DSS’s Impact BioMedical Successfully Synthesizes First Quantum-Based Compound DSS’s Impact BioMedical Reports Positive Test Results for its 3FDB “DEET Booster” Technology DSS Promotes Todd D. Macko to CFO DSS Continues to Grow its Healthcare Segment through $1M Investment in Vivacitas Oncology DSS’s Impact BioMedical to Research Plant-Based Preservation Booster in Collaboration with Thomas Swan Co. DSS’s Impact BioMedical Announces Second US Patent Issued for its Proprietary Equivir Compound DSS’s Impact Biomedical Provides Updates on Key Research Projects and Global Licensing Opportunities DSS Forms Liquid Value Asset Management to Capitalize on Algorithmic Trading Opportunities with Attractive Risk Adjusted Returns DSS Adds Ivy Brook Medical Center to its American Medical REIT Portfolio Aegis Capital Corp. acted as Sole Bookrunner on a $50 Million Public Offering of Common Stock Including Exercise of the Over-Allotment for Document Security Systems, Inc. (NYSE American: DSS) Document Security Systems, Inc. Closes $50.025 Million Public Offering of Common Stock Including Exercise of the Over-Allotment DSS’s Impact BioMedical Receives US Patent for its Functional Fragrance Formulation Mosquito Repellant Booster Document Security Systems, Inc. Prices $43.5 Million Public Offering of Common Stock DSS Expands Footprint of DSS Securities through Acquisition of 24.9% of Broker-Dealer Sentinel Brokers Company DSS Launches DSS PureAir, Inc. and Makes Investment into Innovative Proactive Air and Surface Purification Solutions Technology from Puradigm LLC DSS Sells its DSS Digital Division to Proof Authentication Corporation DSS’s Premier Packaging Subsidiary Expands Operations with New 105,000 Sq. Ft. Facility to Meet Growing Customer Demand DSS Expands its Healthcare Segment through Investment in Vivacitas Oncology DSS Launches Alset Solar to Develop Utility-Scale Solar Farms at Superfund Sites and Other Underutilized Properties UPDATE - DSS’s Impact BioMedical Receives Notice of Allowance from USPTO for Equivir Patent DSS’s Impact BioMedical Receives Notice of Allowance from USPTO for Equivir Patent DSS Releases Full Year 2020 Financial Results: Income From Continuing Operations Increased $5.7 Million in 2020 Document Security Systems Strengthens Its Interest in Sharing Services Global Corporation through $30 Million Investment Document Security Systems Builds Out DSS Securities Ecosystem through Investments in WestPark Capital and BMI Capital Aegis Capital Corp. Acted as Sole Bookrunner on a $39.7 Million Upsized Follow-On Offering for Document Security Systems, Inc. (NYSE American: DSS) Document Security Systems, Inc. Closes $39.7 Million Upsized Public Offering of Common Stock Document Security Systems, Inc., Coinstreet Partners and GSX Group Collaborate to Develop Digital Asset Exchange Business in the US Document Security Systems, Inc. Prices $34.5 Million Upsized Public Offering of Common Stock DSS Provides Update on Impact BioMedical Share Dividend Document Security Systems, Inc. Announces Exercise of Full Over-Allotment Option Aegis Capital Corp. acted as Sole Bookrunner on a $24.0 Million Upsized Follow-On Offering for Document Security Systems, Inc. (NYSE American:DSS) Document Security Systems, Inc. Closes $24.0 Million Upsized Public Offering of Common Stock Document Security Systems, Inc. Prices $24.0 Million Upsized Public Offering of Common Stock DSS Expands Nutraceutical Product Lines through Impact BioMedical’s Investment in Nano Nutraceutical Contract Manufacturer Nano9 DSS’s Impact BioMedical Receives Notice of Allowance for 3F Biofragrance Patent DSS Wholly Owned Subsidiary Impact BioMedical Announces Exclusive Distribution Agreement with BioMed Technology DSS Plans to Change Name to Alset, Inc. to Better Reflect Sweeping Organizational Changes and Ongoing Business Expansions DSS Promotes Todd Macko to Interim CFO DSS Reports Record $5.4M Net Income, $1.20 per Share, in Third Quarter 2020 Two DSS Board Members Join Sharing Services Global Corp. Board DSS Reiterates Plans for Impact BioMedical Share Dividend Impact BioMedical Initiates Bioplastics Research Collaboration with One of World’s Largest Plastic Manufacturers DSS Announces Multi-Year Contract Valued at $9.6M with One of World’s Largest Photography and Image Sharing Companies DSS Announces Record Date for Impact BioMedical Share Dividend DSS Interview to Air on Bloomberg International on the RedChip Money Report DSS Completes Impact BioMedical Acquisition DSS Announces Second Quarter 2020 Financial Results Document Security Systems Prices $3.4 Million Underwritten Public Offering of Common Stock DSS Announces Update On the Acquisition of Impact Biomedical Document Security Systems, Inc. Announces Exercise of Full Over-Allotment Option by Underwriter in Public Offering Impact Biomedical Announces Positive Results from its In-Vitro Testing of Equivir and Linebacker, its Compounds for the Treatment of COVID-19 Document Security Systems Prices $6.43 Million Underwritten Public Offering of Common Stock Document Security Systems, Inc. Closes $6 Million Underwritten Public Offering of Common Stock Document Security Systems Closes $3.4 Million Underwritten Public Offering of Common Stock DSS Announces its AuthentiGuard as a Service Anti-Counterfeiting App is now Available on The App Store Document Security Systems Announces Multi-Year Contract Valued at $6 Million Per Annum with One of World’s Largest Retailers Global PPE Supplier Becomes Early Adopter of Document Security Systems’ New AuthentiGuard as a Service Anti-Counterfeiting Technology Document Security Systems Closes $6.43 Million Underwritten Public Offering of Common Stock Document Security Systems, Inc. Announces Full Exercise of Over-Allotment Option by Underwriter in Public Offering Update on Acquisition of Impact Biomedical, Inc.